Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 HKD | -1.32% | -3.85% | -16.67% |
Apr. 01 | PuraPharm's Net Loss Shrinks in 2023; Revenue Falls 9% | MT |
Mar. 28 | PuraPharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2021 | 660M 84.53M | Sales 2022 | 448M 57.42M | Capitalization | 506M 64.8M |
---|---|---|---|---|---|
Net income 2021 | -122M -15.63M | Net income 2022 | -120M -15.38M | EV / Sales 2021 | 1.14 x |
Net Debt 2021 | 436M 55.86M | Net Debt 2022 | 427M 54.76M | EV / Sales 2022 | 2.08 x |
P/E ratio 2021 |
-2.62
x | P/E ratio 2022 |
-4.2
x | Employees | 662 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 47.06% |
1 day | -1.32% | ||
1 week | -3.85% | ||
Current month | +2.74% | ||
3 months | -3.85% | ||
6 months | -25.00% | ||
Current year | -16.67% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Ling Chan
CEO | Chief Executive Officer | 63 | 98-05-04 |
Hang Woon Ma
SAM | Sales & Marketing | - | - |
Pui Hung
HRO | Human Resources Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Kwok Wah Ho
BRD | Director/Board Member | 65 | 15-06-11 |
Lim Kin Leung
BRD | Director/Board Member | 70 | 15-06-11 |
Yu Ling Chan
CEO | Chief Executive Officer | 63 | 98-05-04 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-19 | 0.75 | -1.32% | 20 500 |
24-05-17 | 0.76 | 0.00% | 133,000 |
24-05-16 | 0.76 | -1.30% | 32,000 |
24-05-14 | 0.77 | -1.28% | 38,500 |
24-05-13 | 0.78 | 0.00% | 263,500 |
Delayed Quote Hong Kong S.E., May 19, 2024 at 09:31 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.67% | 38.48M | |
+42.38% | 6.26B | |
-15.86% | 4.49B | |
+6.36% | 3.29B | |
-11.28% | 3.12B | |
-3.23% | 2.5B | |
+45.24% | 1.94B | |
-7.89% | 1.68B | |
-0.98% | 1.63B | |
-11.32% | 1.56B |
- Stock Market
- Equities
- 1498 Stock